Connect with us

Business

Not even a bullet could stop Matthew C. Nickerson

mm

Published

on

How Matthew C. Nickerson, Co-Founder & CEO of the Iconic Nutraceutical brand VASO6, Plans on Disrupting the Health & Wellness Industry.

Despite having 14 years of experience in the surgical fields of Orthopedic, Trauma, Pediatrics, General and Plastic surgery, Matthew Nickerson decided to change his career path in favor of embracing an entrepreneurial pursuit. At the age of 34, he decided to take the leap and not only changed his profession but also moved to Florida with absolutely no financial security or health insurance.  The University of South Florida Research Park and hometown to one of his fellow Co-Founders would be the base of operations for what the world would come to know as VASO6.

His only asset was his strong will to succeed. For him, there was no going back to the old life. His goal wasnt to chase dollars, rather he wanted to build something from scratch that would earn him a living, while bringing value to all living creatures throughout the world. With his mentor and business partner Mike Sperduti & Co-Founder JR Huddleston by his side, Matthew successfully co-created VASO6 using both his academic and athletic background. This patented green tea performance extract was a proprietary blend of gallate-enhanced oligomers derived from green tea leaf. It was a highly concentrated preponderance of bioactive catechins, which made for optimized physical output and increased health benefits.

Matthew believes that the most rewarding part of creating VASO6 is to witness someone else’s health and wellness journey and knowing he played a role in it. “Having my VASO6 add value to another people’s health, and oftentimes fitness journey is one of the greatest privileges in my life,” says Matthew, “and occupying a front-row seat to their passion and enthusiasm as they achieve their health and wellness goals will never get old for me.”

He also published a human peer-reviewed study – the first ever to demonstrate that green tea-based supplements could enhance localized blood flow in humans following a post resistance exercise bout.

https://jissn.biomedcentral.com/articles/10.1186/s12970-020-00358-5

This body of VASO6 research included significant pre-clinical and pilot human and animal studies as well as human proteomics data, all supporting the overwhelming demand for the benefits that were a result of VASO6.

Currently, VASO6 is present in a multitude of different markets with distribution spanning over 47 different countries. Markets of particular interest for continued research & commercialization in VASO6 include men’s health, energy, weight loss, brain health, functional food for humans and animals, etc. All of which, Matthew plans to study and explore wherever the science leads him and his team. He further wishes to create more solutions to different ailments and spread health, happiness, and wellness all over the world; and by the looks of the global landscape hes off to a great start.

The idea of Bigtime Daily landed this engineer cum journalist from a multi-national company to the digital avenue. Matthew brought life to this idea and rendered all that was necessary to create an interactive and attractive platform for the readers. Apart from managing the platform, he also contributes his expertise in business niche.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

How Technology Drives Value Creation in Private Equity

mm

Published

on

How technology drives value creation in private equity is now one of the most actively debated topics among institutional investors and fund managers. A decade ago, technology was largely a cost center in PE-backed companies. Today it sits at the center of margin improvement, revenue growth, and exit multiple expansion. Firms that figured this out early are generating better returns with less reliance on financial engineering.

The shift happened for a practical reason. As interest rates rose and deal multiples compressed, financial leverage stopped doing the heavy lifting. Operational improvement became the primary value creation lever. Technology accelerated what was possible within the ownership period.

How Technology Drives Value Creation in Private Equity Operations

Operational improvement through technology produces the most measurable results. PE firms apply technology tools to reduce costs, increase throughput, and improve decision-making speed inside their companies.

Digital Process Automation in PE-Backed Companies

Manual processes in back-office and production functions carry real costs. They consume labor, generate errors, and slow down the information flow that management teams depend on. Automation tools eliminate these costs without requiring headcount reductions that disrupt company culture.

The most impactful automation deployments in PE-backed operations include:

  • Accounts payable and receivable automation that compresses billing cycles and reduces days sales outstanding
  • Production scheduling software that reduces downtime and improves throughput in manufacturing environments
  • Inventory management systems that cut carrying costs by aligning purchasing with real-time demand signals
  • Quality control automation that reduces defect rates and warranty claims in product-based businesses

ZCG Consulting (“ZCGC”) works with companies across industrials, manufacturing, packaging, and consumer products to identify and implement automation programs tied to specific financial outcomes. The approach connects technology investment to measurable margin improvement rather than treating automation as a general upgrade.

Data Infrastructure as a Value Creation Tool

Many PE-backed companies arrive under new ownership with fragmented data systems. Different departments use different tools. Reporting requires manual consolidation. Leadership makes decisions with incomplete information.

Fixing that infrastructure creates immediate value. Integrated data systems give management teams real-time visibility into revenue, cost, and operational performance. That visibility accelerates decisions and surfaces problems before they become material.

James Zenni, founder and CEO of ZCG with over 30 years of capital markets experience, has consistently emphasized that information quality drives investment performance. That view shapes how ZCG approaches technology investment across the companies in its portfolio.

Technology Drives Value Creation in Private Equity Through Revenue Growth

Cost reduction gets most of the attention in PE operational improvement, but technology also drives revenue growth. The mechanisms are different, and they compound differently over a hold period.

E-Commerce and Digital Customer Acquisition

Companies that sell primarily through traditional channels often leave significant revenue on the table. Adding e-commerce capabilities or investing in digital customer acquisition expands the addressable market without proportional cost increases.

PE firms that invest in digital revenue channels generate higher growth rates during the hold period. That growth rate difference translates directly into exit multiple expansion.

Revenue growth technology applications in PE-backed companies include:

  • E-commerce platform buildouts that open direct-to-consumer channels alongside existing wholesale relationships
  • Customer relationship management systems that improve retention and increase repeat purchase rates
  • Digital marketing infrastructure that lowers customer acquisition costs through better targeting and attribution
  • Pricing optimization tools that identify margin improvement opportunities without volume loss

Technology-Enabled Customer Experience Improvements

Customer retention is cheaper than customer acquisition. Technology investments in customer experience, service speed, and product quality consistency reduce churn. Lower churn produces more predictable revenue. More predictable revenue supports higher exit valuations.

ZCG deploys Haptiq Technologies and Solutions, its 300-plus-person technology division, to support digital transformation across its companies. The platform was founded 20 years ago and manages approximately $8 billion in AUM. It brings implementation resources that most individual companies cannot afford to build internally. That capability gives ZCG’s companies faster access to technology improvements at lower execution risk.

Building Technology Capability Within PE-Backed Companies

Technology investment during the hold period creates value in two ways. It improves financial performance during ownership. It also makes the business more attractive to the next buyer.

Strategic buyers and later-stage PE funds pay premium multiples for companies with modern technology infrastructure. A business with integrated systems, clean data, and digital revenue channels commands a better price. A comparable business running on legacy platforms does not.

The ZCG Team structures technology investment as part of the initial value creation plan for each company. Priorities get set at entry based on the gap between current capability and acquirer expectations.

This pre-sale positioning approach changes how technology investment gets funded and sequenced during the hold period. Projects that improve financial performance and exit readiness simultaneously get prioritized. Projects with long payback periods that do not improve the sale narrative get deferred.

How technology drives value creation in private equity is ultimately about execution discipline. The tools matter less than the clarity of the financial objective each technology investment must achieve.

Continue Reading

Trending